BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

23793

0

QUESTLAB

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

QUEST LABORATORIES LTD performance

Today’s low

Today’s high

₹ 92.30 ₹ 94.20
₹ 92.30

52 week low

52 week high

₹ 75.15 ₹ 196.80
₹ 92.30

Open Price

₹ 94.20

Prev. Close

₹ 92.00

Volume (Shares)

7200.00

Total traded value

₹ 6.64

Upper Circuit

₹ 110.40

Lower Circuit

₹ 73.60

info

QUEST LABORATORIES LTD Share Price Update

As of the latest trading session, QUEST LABORATORIES LTD share price is currently at ₹ 92.3, which is up by ₹ 0.30 from its previous closing. Today, the stock has fluctuated between ₹ 92.30 and ₹ 94.20. Over the past year, QUEST LABORATORIES LTD has achieved a return of -33.62 %. In the last month alone, the return has been -13.65 %. Read More...

QUEST LABORATORIES LTD fundamentals


  • Market cap (Cr)

    151.30

  • P/E Ratio (TTM)

    11.11

  • Beta

    0.16

  • Book Value / share

    49.92

  • Return on equity

    46.13%

  • EPS (TTM)

    8.28

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    2.34

info icon alternate text
  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

info icon alternate text

QUEST LABORATORIES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 20.48
Operating Expense 0.00
Net Profit 2.34
Net Profit Margin (%) 11.42
Earnings Per Share (EPS) 1.96
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 21.06
Operating Expense 0.00
Net Profit 1.43
Net Profit Margin (%) 6.79
Earnings Per Share (EPS) 1.33
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 103.91
Operating Expense 89.47
Net Profit 13.57
Net Profit Margin (%) 13.05
Earnings Per Share (EPS) 8.28
EBITDA 20.23
Effective Tax Rate (%) 27.40
Particulars MAR 2024 (Values in Cr)
Revenue 82.56
Operating Expense 68.34
Net Profit 10.09
Net Profit Margin (%) 12.22
Earnings Per Share (EPS) 9.11
EBITDA 15.78
Effective Tax Rate (%) 30.10
Particulars MAR 2023 (Values in Cr)
Revenue 61.64
Operating Expense 54.89
Net Profit 5.04
Net Profit Margin (%) 8.17
Earnings Per Share (EPS) 46.76
EBITDA 8.07
Effective Tax Rate (%) 27.79
Particulars MAR 2022 (Values in Cr)
Revenue 59.48
Operating Expense 53.77
Net Profit 4.11
Net Profit Margin (%) 6.90
Earnings Per Share (EPS) 38.05
EBITDA 6.52
Effective Tax Rate (%) 28.76
Particulars MAR 2021 (Values in Cr)
Revenue 30.36
Operating Expense 29.65
Net Profit 0.66
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 6.07
EBITDA 1.49
Effective Tax Rate (%) 16.45
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.99
ROE % 46.13
ROCE % 57.51
Total Debt to Total Equity 0.21
EBITDA Margin 19.13
Particulars MAR 2023 (Values in Cr)
Book Value / Share 139.97
ROE % 40.16
ROCE % 46.68
Total Debt to Total Equity 0.29
EBITDA Margin 13.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share 92.64
ROE % 51.73
ROCE % 54.76
Total Debt to Total Equity 0.39
EBITDA Margin 10.98
Particulars MAR 2021 (Values in Cr)
Book Value / Share 54.58
ROE % 11.21
ROCE % 12.25
Total Debt to Total Equity 0.52
EBITDA Margin 4.91
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 59.29
Total Liabilities 59.29
Total Equity 28.64
Share Outstanding 11937600
Price to Book Ratio 0.00
Return on Assets (%) 17.02
Return on Capital (%) 29.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 46.94
Total Liabilities 46.94
Total Equity 15.09
Share Outstanding 1078760
Price to Book Ratio 0.00
Return on Assets (%) 10.74
Return on Capital (%) 26.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.56
Total Assets 34.79
Total Liabilities 34.79
Total Equity 9.99
Share Outstanding 1078760
Price to Book Ratio 0.00
Return on Assets (%) 11.79
Return on Capital (%) 31.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.41
Total Assets 18.39
Total Liabilities 18.39
Total Equity 5.88
Share Outstanding 1078760
Price to Book Ratio 0.00
Return on Assets (%) 3.56
Return on Capital (%) 7.34
Particulars MAR 2024 (Values in Cr)
Net Income 14.44
Cash from Operations 7.21
Cash from Investing -5.02
Cash from Financing 2.03
Net change in Cash 0.02
Free Cash Flow 8.15
Particulars MAR 2023 (Values in Cr)
Net Income 6.98
Cash from Operations 5.67
Cash from Investing -3.82
Cash from Financing 0.00
Net change in Cash 0.05
Free Cash Flow 8.68
Particulars MAR 2022 (Values in Cr)
Net Income 5.76
Cash from Operations 3.72
Cash from Investing -1.88
Cash from Financing -0.41
Net change in Cash 1.15
Free Cash Flow 5.65
Particulars MAR 2021 (Values in Cr)
Net Income 0.78
Cash from Operations 1.45
Cash from Investing -1.19
Cash from Financing 0.03
Net change in Cash -0.11
Free Cash Flow 2.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.36 27.76 1.99 278.64 34.11 / 77.70
BLISS GVS PHARMA LTD 149.35 18.67 1.49 1573.70 101.00 / 184.95
CIPLA LTD 1505.40 23.06 3.89 121589.70 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 338.10 12.94 2.74 995.06 163.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 3299.05 63.95 28.64 55887.90 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.36 36.36 5.74 278.64 34.11 / 77.70
AMRUTAJAN HEALTH LTD 697.60 39.68 6.17 2016.81 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 10524.65 150.31 34.15 26311.63 6160.25 / 10653.05
BLISS GVS PHARMA LTD 149.35 22.80 1.48 1573.70 101.00 / 184.95

QUEST LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
92.30 0.32 redarrow
red-green-graph indicator
10 Bearish
6 Bullish
  • 5 Days 89.60
  • 26 Days 94.70
  • 10 Days 89.30
  • 50 Days 101.80
  • 12 Days 89.80
  • 100 Days 110.10
  • 20 Days 92.60
  • 200 Days 115.80
91.50 PIVOT

First Support

88.50

First Resistance

95.00

Second Support

85.00

Second Resistance

98.00

Third Support

82.00

Third Resistance

101.50

RSI

46.11

ADX

32.23

MACD

-4.86

Williams % R

-42.39

Commodity Channel Index (CCI)

-9.33

Date

2025-06-13

Week

47200.00

Same Day

16800.00

Month

52473.00

1 Year

0.17

3 Year

0.22

Over 1 Month

-13.65%

down

Over 1 Year

-33.62%

down

Over 3 Months

-11.79%

down

Over 3 Years

0.00%

down

Over 6 Months

-16.36%

down

Over 5 Years

0.00%

down

QUEST LABORATORIES LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
32.76%
Promoter Holdings
66.21%
FII
0.95%
DII
0.07%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Anil Kumar Sabarwal 1.020805E7 (62.29%) Shareholding of Promoter and Promoter Group
Tejaswini Sabarwal 417800.0 (2.55%) Shareholding of Promoter and Promoter Group
Vinayak Sabarwal 224650.0 (1.37%) Shareholding of Promoter and Promoter Group
Priti Kamlesh Gandhi 200000.0 (1.22%) Public Shareholding
Kamlesh Chandulal Gandhi 200000.0 (1.22%) Public Shareholding
Sandeep Singh 175200.0 (1.07%) Public Shareholding
Anil Sabarwal Huf 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Qas Analytical Services Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vivek Chouhan 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Padma 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shyam Chouhan 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sakshi Sabarwal 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Kiran Sachdeva 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Manju Singh 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

QUEST LABORATORIES LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

QUEST LABORATORIES LTD Share Price

Quest Laboratories Ltd was originally incorporated under the name 'Quest Laboratories Private Limited' vide Certificate of Incorporation dated June 01, 1998, issued by the Registrar of Companies Madhya Pradesh, Gwalior. Thereafter, the status of the Company changed to Public Limited and the name of Company was changed to 'Quest Laboratories Limited' vide fresh Certificate of Incorporation issued on January 23, 2024, by Registrar of Companies, Centralised Processing Centre.

The Company is engaged in manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark 'Quest Laboratories Limited'. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.

The Company holds WHO Schedule M GMP, and GLP certifications, adhering to the stringent guidelines set by the World Health Organization. It also possesses Good Laboratory Practice (GLP) certificate issued by Food & Drug Administration, Bhopal, Madhya Pradesh, indicating its commitment to maintaining high standards of quality and compliance in laboratory operations, particularly within the pharmaceutical sector.

The Company has approvals to manufacture more than 600 formulations. It routinely manufacture 250 to 300 types of formulations
based on market demand and limited formulation lines. However, it has versatile manufacturing facility through which it produce multiple products using a combination of processes. The flexible manufacturing infrastructure helps them change product mix in response to changes in market demand. In addition, the Company has complete infrastructure of formulation development, pilot plant and validation studies and is able to develop efficient and cost-effective specialized processes at short notice.

The Company is an ISO 9001:2015 in accordance with the requirements Quality Management System standard.

The Company is proposing the Initial Public Offer of 44,50,000 Equity Shares through Fresh Issue.

Parent organization Indian Private
NSE symbol QUESTLAB
Founded 1998
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Quest Laboratories Ltd?

Answer Field

Quest Laboratories Ltd share price is for NSE ₹ 92.30 & for BSE ₹ 0.00 as on Jun 16 2025 02:02 PM.

What is the Market Cap of Quest Laboratories Ltd Share?

Answer Field

The market cap of Quest Laboratories Ltd for NSE ₹ 151.30 & for BSE ₹ 0.00 as on Jun 16 2025 02:02 PM.

What is the 52 Week High and Low of Quest Laboratories Ltd?

Answer Field

The 52 Week High and Low of Quest Laboratories Ltd for NSE is ₹ 196.80 and ₹ 75.15 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Quest Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -33.62%.

What is the P/E Ratio of Quest Laboratories Ltd Share?

Answer Field

As on Jun 16 2025 02:02 PM the price-to-earnings (PE) ratio for Quest Laboratories Ltd share is 11.11.

What is the PB ratio of Quest Laboratories Ltd Share?

Answer Field

As on Jun 16 2025 02:02 PM, the price-to-book (PB) ratio for Quest Laboratories Ltd share is 49.92.

How to Buy Quest Laboratories Ltd Share?

Answer Field

You can trade in Quest Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Quest Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Quest Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Quest Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|